Gongzhi Wu
Lishui, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
ASO Visual Abstract: A Prospective Multicenter Comparative Cohort Study of Neoadjuvant Sintilimab Plus Chemotherapy and Chemoradiotherapy in Resectable Clinical Node-Positive Esophageal Squamous Cell Carcinoma.
Journal: Annals of surgical oncology
Published: July 20, 2026
A Prospective Multicenter Comparative Cohort Study of Neoadjuvant Sintilimab Plus Chemotherapy and Chemoradiotherapy in Resectable Clinical Node-Positive Esophageal Squamous Cell Carcinoma.
Journal: Annals of surgical oncology
Published: January 21, 2026
TFDP1 activates SPC25-mediated glutamine metabolism to repress anti-tumor immunity of NK cells in lung adenocarcinoma.
Journal: Expert review of clinical immunology
Published: June 24, 2025
PLA2G2D fosters angiogenesis in non-small cell lung cancer through aerobic glycolysis.
Journal: Growth factors (Chur, Switzerland)
Published: January 02, 2024
Identification of a dysregulated ceRNA network modulated by copy number variation-driven lncRNAs in lung squamous cell carcinoma.
Journal: Environmental and molecular mutagenesis
Published: April 14, 2022
MiR-129-2-3p Inhibits Esophageal Carcinoma Cell Proliferation, Migration, and Invasion via Targeting DNMT3B.
Journal: Current molecular pharmacology
Published: June 26, 2021
miR-182-5p Serves as an Oncogene in Lung Adenocarcinoma through Binding to STARD13.
Journal: Computational and mathematical methods in medicine
Published: May 07, 2021
MiR-196b Promotes the Invasion and Migration of Lung Adenocarcinoma Cells by Targeting AQP4.
Journal: Technology in cancer research & treatment
Published: January 18, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026